No obvious advantage of hyperthermic intraperitoneal chemotherapy after interval debulking surgery in the treatment of advanced ovarian cancer: A retrospective study

Overview of attention for article published in Frontiers in Surgery, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 1 X user

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 1 X post from an account with 1,046 followers.

New Research: No obvious advantage of hyperthermic intraperitoneal chemotherapy after interval debulking surgery in the treatment of advanced ovarian cancer: A retrospective study: Objective To study the efficacy of interval debulking surgery… https://t.c

17 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.